منابع مشابه
Molecular mechanisms involved in multidrug resistance in breast cancer therapy
Breast cancer is the most prevalent cancer in women. Chemotherapy is the main strategy in the treatment of this disease especially in the advanced form of the disease. Despite the recent progress in the development of new chemotherapy, the effectiveness of these drugs has dramatically reduced due to multidrug resistance. The phenotype of multidrug resistance (MDR) can occur through different me...
متن کاملGlioblastoma Multiforme Therapy and Mechanisms of Resistance
Glioblastoma multiforme (GBM) is a grade IV brain tumor characterized by a heterogeneous population of cells that are highly infiltrative, angiogenic and resistant to chemotherapy. The current standard of care, comprised of surgical resection followed by radiation and the chemotherapeutic agent temozolomide, only provides patients with a 12-14 month survival period post-diagnosis. Long-term sur...
متن کاملDissecting resistance mechanisms in melanoma combination therapy
quiescent and physiological autophagy interact in response to therapies. Figure 2. A. Calibrating the model with in vitro data. B. Validating model predictions with in vitro combination therapy. Abstract— We present a compartment model that explains melanoma cell response and resistance to mono and combination therapies. Model parameters were estimated by utilizing an optimization algorithm to ...
متن کاملMechanisms of Resistance to Photodynamic Therapy: An Update
© Springer International Publishing Switzerland 2015 V. Rapozzi, G. Jori (eds.), Resistance to Photodynamic Therapy in Cancer, Resistance to Targeted Anti-Cancer Therapeutics 5, DOI 10.1007/978-3-319-12730-9_2 A. Casas () · C. Perotti · G. Di Venosa · A. Batlle Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP), CONICET and Hospital de Clínicas José de San Martín, University of Bue...
متن کاملMolecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy
Deregulation of the phosphatidylinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) signaling pathway occurs frequently in a wide range of human cancers and is a major driving force in tumorigenesis. Thus, small molecules targeting this pathway are under active development as anticancer therapeutics. Although small-molecule inhibitors of the PI3K-mTOR pathway have shown promising...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neoplasia
سال: 2014
ISSN: 1476-5586
DOI: 10.1016/j.neo.2014.04.005